Neuphoria Therapeutics Inc (NEUP) — Free Cash Flow Generation Index

Latest as of June 2025: 1.00x

Neuphoria Therapeutics Inc (NEUP) has a Free Cash Flow Generation Index of 1.00x as of June 2025. Free cash flow of $73.57 Million represents 1% of operating cash flow ($73.57 Million). Explore how much does Neuphoria Therapeutics Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$73.57 Million
USD

Operating Cash Flow

$73.57 Million
USD

Capital Expenditures

$3.00
USD

Neuphoria Therapeutics Inc Free Cash Flow Generation Index (2015–2025)

Historical FCF Generation Index trend for Neuphoria Therapeutics Inc across 2 annual periods. For the full cash flow conversion analysis, see NEUP cash flow metrics.

Annual Free Cash Flow Generation for Neuphoria Therapeutics Inc (2015–2025)

Year-by-year Free Cash Flow Generation Index for Neuphoria Therapeutics Inc. Check Neuphoria Therapeutics Inc (NEUP) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2025 1.00x $77.23 Million $77.23 Million $0.00 ▲ +20.7%
2015 0.83x $4.09 Million $4.94 Million $846.26K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).